Cited by 29Parkinson's Disease Mechanisms and TreatmentsSleep and related disordersDementia and Cognitive Impairment Research

Timeline of Rapid Eye Movement Sleep Behavior Disorder in Overt Alpha‐Synucleinopathies

Open access
Stang, Cole D., Mullan, Aidan F., Hajeb, Mania, Camerucci, Emanuele, Turcano, Pierpaolo, Martin, Peter, Mielke, Michelle M., Josephs, Keith A. +4 more·2021·Annals of Neurology

Abstract

Objective: The aim was to analyze the timeline, prevalence, and survival of rapid eye movement (REM) sleep behavior disorder (RBD) in patients who developed alpha‐synucleinopathies (Parkinson disease, dementia with Lewy bodies, and Parkinson disease dementia) compared with age‐ and sex‐matched controls in a population‐based incident‐cohort study. Methods: We used a population‐based, 1991 to 2010 incident‐cohort study of alpha‐synucleinopathies. A movement‐disorder specialist reviewed medical records to confirm diagnoses. RBD was diagnosed by reported dream‐enactment symptoms or polysomnography. Probable RBD and polysomnographically confirmed RBD were analyzed separately and combined. Results: Among the 444 incident cases of alpha‐synucleinopathy, 86 were clinically diagnosed with RBD (19.8%), including 30 (35%) by polysomnography and 56 (65%) as probable. The prevalence of idiopathic RBD at alpha‐synucleinopathy diagnosis was 3.4%, increasing to 23.8% after 15 years. Cumulative lifetime incidence was 53 times greater in alpha‐synucleinopathy patients than in controls (odds ratio [OR] = 53.1, 95% confidence interval [CI]: 13.0–217.2, p < 0.0001), higher in dementia with Lewy bodies than in Parkinson disease (OR = 2.57, 95% CI: 1.50–4.40, p = 0.0004), and higher in men than in women with Parkinson disease, dementia with Lewy bodies, or Parkinson disease dementia (OR = 3.70, 95% CI: 2.07–6.62, p < 0.0001), but did not increase mortality risk. Interpretation: Our cohort had RBD incidence of 3.4%. Overall RBD increased to 23.8% after 15 years, with an overall incidence of 2.5 cases per 100 person‐years. With 53 times greater lifetime incidence in alpha‐synucleinopathy patients than in controls, RBD was more likely to develop in dementia with Lewy bodies than in Parkinson disease or Parkinson disease dementia, and in men than in women, but did not increase mortality risk within our cohort. ANN NEUROL 2021;89:293–303

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25952

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Biological mechanisms include neuroinflammation, atherosclerosis, alpha-synucleinopathies, and impaired amyloidβ clearance.

    “Biological mechanisms include neuroinflammation,(312) atherosclerosis,(313) alpha-synucleinopathies (dementia with Lewy bodies and Parkinson disease dementia),(314) and impaired amyloidβ clearance. (315)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stang, C. D., Mullan, A. F., Hajeb, M., Camerucci, E., Turcano, P., Martin, P., Mielke, M. M., Josephs, K. A., Bower, J. H., St Louis, E. K., Boeve, B. F., & Savica, R.
Affiliations
  • Mayo Clinic (US)
  • Department of Neurology Mayo Clinic Rochester MN USA
Corresponding author
Savica, Rodolfo
Venue
Annals of Neurology
Publisher
Wiley
Published
2020-11-20
Volume
89
Issue
2
Pages
293-303
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W3095559746
Cited by
29
References
45
Citations by year
2026: 1 · 2025: 11 · 2024: 6 · 2023: 3 · 2022: 4 · 2021: 4
FWCI
1.19
Type
journal article
Language
en
Open access
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Center for Advancing Translational Sciences (UL1 TR002377)
  • National Institute on Aging (R01 AG034676)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
rapid eye movement sleep behavior disorder, synucleinopathies, Parkinson's disease, dementia with Lewy bodies, Parkinson's disease dementia, sex differences, dream enactment, Lewy bodies, REM sleep
MeSH terms
Synucleinopathies, Aged, Aged, 80 and over, Female, Humans, Male, Mortality, Parkinson Disease, Incidence, Prevalence, Case-Control Studies, Polysomnography, Sex Distribution, Disease Progression, REM Sleep Behavior Disorder, Lewy Body Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review